Immediate Postoperative Low Platelet Counts after Living Donor Liver Transplantation Predict Early Allograft Dysfunction

Medicine (United States)

Volumn 94, Issue 34, 2015, Pages e1373-

  Li, Lei ^a   Wang, Haiqing ^b   Yang, Jian ^a   Jiang, Li ^a   Yang, Jiayin ^a   Wang, Wentao ^a   Yan, Lvnan ^a   Wen, Tianfu ^a   Li, Bo ^a   Xu, Mingqing ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADULT TO ADULT LIVING DONOR LIVER TRANSPLANTATION; ARTICLE; EARLY ALLOGRAFT DYSFUNCTION; ERYTHROCYTE TRANSFUSION; FEMALE; FULMINANT HEPATIC FAILURE; GRAFT DYSFUNCTION; HEPATORENAL SYNDROME; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER REGENERATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; OPERATION DURATION; OPERATIVE BLOOD LOSS; PLASMA TRANSFUSION; PORTAL VEIN THROMBOSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; ADVERSE EFFECTS; BLOOD; CHINA; END STAGE LIVER DISEASE; GRAFT SURVIVAL; LIVING DONOR; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; TIME; TREATMENT OUTCOME;

ADULT; CHINA; END STAGE LIVER DISEASE; FEMALE; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PLATELET COUNT; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; ROC CURVE; THROMBOCYTOPENIA; TIME FACTORS; TREATMENT OUTCOME;

EID: 84944883876     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001373     Document Type: Article

References (32)

1. Dahm F, Georgiev P, Clavien PA. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant. 2005;5:2605-2610.
2. Kim J, Yi NJ, Shin WY, et al. Platelet transfusion can be related to liver regeneration after living donor liver transplantation. World J Surg. 2010;34:1052-1058.
3. Witters P, Freson K, Verslype C, et al. Review article: blood platelet number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther. 2008;27:1017-1029.
4. Nocito A, Georgiev P, Dahm F, et al. Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice. Hepatology. 2007;45:369-376.
5. Parker RI. Etiology and significance of thrombocytopenia in critically ill patients. Crit Care Clin. 2012;28:399-411vi.
6. Lesurtel M, Graf R, Aleil B, et al. Platelet-derived serotonin mediates liver regeneration. Science. 2006;312:104-107.
7. Matsuo R, Nakano Y, Ohkohchi N. Platelet administration via the portal vein promotes liver regeneration in rats after 70% hepatect-omy. Ann Surg. 2011;253:759-763.
8. Murata S, Hashimoto I, Nakano Y, et al. Single administration of thrombopoietin prevents progression of liver fibrosis and promotes liver regeneration after partial hepatectomy in cirrhotic rats. Ann Surg. 2008;248:821-828.
9. Myronovych A, Murata S, Chiba M, et al. Role of platelets on liver regeneration after 90% hepatectomy in mice. J Hepatol. 2008;49:363-372.
10. Ishizawa T, Hasegawa K, Kokudo N, et al. Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg. 2009;144:46-51.
11. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1, 803 consecutive cases over the past decade. Ann Surg. 2002;236:397-406discussion 397-406.
12. Poon RT, Fan ST, Lo CM, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240:698-708discussion 610-708.
13. Taketomi A, Kitagawa D, Itoh S, et al. Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients. J Am Coll Surg. 2007;204:580-587.
14. Alkozai EM, Nijsten MW, de Jong KP, et al. Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection. Ann Surg. 2010;251: 300-306.
15. Li C, Wen TF, Yan LN, et al. Predictors of patient survival following living donor liver transplantation. Hepatobiliary Pancreat Dis Int. 2011;10:248-253.
16. Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010;16:943-949.
17. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
18. Lesurtel M, Raptis DA, Melloul E, et al. Low platelet counts after liver transplantation predict early post-transplant survival: the "60-5 criterion". Liver Transpl. 2014;20:147-155.
19. Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis. Transplantation. 1993;55:807-813.
20. Briceno J, Ciria R. Early graft dysfunction after liver transplantation. Transplant Proc. 2010;42:631-633.
21. Kaibori M, Kubo S, Nagano H, et al. Clinicopathological features of recurrence in patients after 10-year disease-free survival following curative hepatic resection of hepatocellular carcinoma. World J Surg. 2013;37:820-828.
22. Bleibel W, Caldwell SH, Curry MP, et al. Peripheral platelet count correlates with liver atrophy and predicts long-term mortality on the liver transplant waiting list. Transpl Int. 2013;26:435-442.
23. McCaughan GW, Herkes R, Powers B, et al. Thrombocytopenia post liver transplantation. Correlations with pre-operative platelet count, blood transfusion requirements, allograft function and outcome. J Hepatol. 1992;16:16-22.
24. Chatzipetrou MA, Tsaroucha AK, Weppler D, et al. Thrombocytope-nia after liver transplantation. Transplantation. 1999;67:702-706.
25. Richards EM, Alexander GJ, Calne RY, et al. Thrombocytopenia following liver transplantation is associated with platelet consumption and thrombin generation. Br J Haematol. 1997;98:315-321.
26. Chang FY, Singh N, Gayowski T, et al. Thrombocytopenia in liver transplant recipients: predictors, impact on fungal infections, and role of endogenous thrombopoietin. Transplantation. 2000;69:70-75.
27. Eyraud D, Granger B, Ionescu C, et al. Thrombocytopenia, splenomegaly, and portal blood flow in patients who have undergone liver transplantation for cirrhosis. Liver Transpl. 2012;18:340-346.
28. Lisman T, Pittau G, Leite FJ, et al. The circulating platelet count is not dictated by the liver, but may be determined in part by the bone marrow: analyses from human liver and stem cell transplantations. J Thromb Haemost. 2012;10:1624-1630.
29. Nascimbene A, Iannacone M, Brando B, et al. Acute thrombocyto-penia after liver transplant: role of platelet activation, thrombopoietin deficiency and response to high dose intravenous IgG treatment. J Hepatol. 2007;47:651-657.
30. Peck-Radosavljevic M, Wichlas M, Zacherl J, et al. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood. 2000;95:795-801.
31. Trotter JF, Gillespie BW, Terrault NA, et al. Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl. 2011;17:409-417.
32. Graham JA, Guarrera JV. Looking into the crystal ball: the 60-5 criterion-a newly proposed predictor of severe complications after liver transplantation. Liver Transpl. 2014;20:127-129.